The role of Andrographis paniculata L. modified nanochitosan for lamivudine encapsulation efficiency enhancement and in vitro drug release study

Author(s):  
Harits Atika Ariyanta ◽  
Siti Chodijah ◽  
Fakhrur Roji ◽  
Ashfar Kurnia ◽  
Dewangga Oky Bagus Apriandanu
Author(s):  
Nani Tadhi ◽  
Himansu Chopra ◽  
Gyanendra Kumar Sharma

Transdermal patch is a drug delivery device in which the drugs are incorporated and is design in such a way that it releases the drug in sustained and at predetermined rate to deliver the drug through the skin to the systemic circulation painlessly. The aim of this research study was to formulate a controlled and sustained release transdermal matrix type patch of Methimazole. The matrix patch was prepared by solvent casting method using a various polymer in different concentration, HPMC (hydrophilic), Eudragit RL100 and Ethyl cellulose (hydrophobic) polymer. Total 9 prototype formulation were prepared and it was subjected for various evaluation test; weight uniformity, Folding endurance, thickness, Drug content, percent moisture content, percent Moisture uptake and In-vitro drug release study using Franz diffusion cell. The in-vitro CDR% data was fit into kinetics model to see the release kinetics from the patches. The Formulation F5 was choosen as a best formulation according to in-vitro drug release study. The in-vitro release was found 81.12 % in 12 hours, it followed zero order kinetics. The nature of polymer and concentration ratio of polymers plays a crucial role for obtaining a good transdermal patch design; therefore optimisation is very important step to formulate a desired TDDS. Therefore the result of the study encourages a further study and is hopeful that the present study would contribute to the recent pharmaceutical research for formulation development.


INDIAN DRUGS ◽  
2020 ◽  
Vol 57 (07) ◽  
pp. 52-57

The aim of this research was to develop mucoadhesive buccal patches of nicergoline by using Factorial Design of Experiment, in order to provide a sustained release of drug into the systemic circulation. A 33 factorial experimental design was employed for optimization and to study the effect of formulation variables on responses R1 (% swelling index), R2 (% drug content), R3 (mucoadhesion time) and R4 (mucoadhesion strength). In vitro drug release study was performed on the optimized formulations. All the prepared formulations had good mechanical strength, mucoadhesion strength, neutral surface pH and drug content up to 98.17%. In vitro drug release study revealed that F-5 formulation showed promising sustained drug release profile (98.21%) for over 8 h and could be a potential substitute for marketed conventional formulations. The developed formulation (F5) was found to be optimized with considerably good stability and extended drug release profile.


2020 ◽  
Vol 32 (2) ◽  
pp. 1785-1791
Author(s):  
Dhanya Arambath Thankappan ◽  
Haridas Karickal Raman ◽  
Joby Jose ◽  
Sudheesh Sudhakaran

2018 ◽  
Vol 89 (2) ◽  
pp. 521-530 ◽  
Author(s):  
J. M. C. Teixeira ◽  
J. S. V. Alburquerque ◽  
E. B. Duarte ◽  
S. A. Silva ◽  
R. E. F. Q. Nogueira

Sign in / Sign up

Export Citation Format

Share Document